Generic medicine
Amoxicillin + clavulanic acid
Amoxicillin + clavulanic acid
Data statusRegistration & price fields require source verification.
53brands/products
14companies
53with current prices
Pakistan brand index
53 resultsAvailable brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price |
|---|---|---|---|---|---|---|
| Stamentin | STALLION PHARMACEUTICALS PVT LTD | 500 mg + 100 mg | Injection | 1 Vial | 077233 | PKR 172.582026-07-27 |
| Termibex | Highnoon Laboratories Ltd | 1 g + 0.2 g | Injection | 10 | 039864 | PKR 2,791.102026-07-27 |
| Veroclav | CSH Pharmaceuticals (Pvt.) Ltd., | 500 mg + 125 mg | Tablet | 1x6’s | 071526 | PKR 244.362026-07-27 |
| Veroclav | CSH Pharmaceuticals (Pvt.) Ltd., | 875 mg + 125 mg | Tablet | 1x6’s | 071525 | PKR 309.222026-07-27 |
| Veroclav | CSH Pharmaceuticals (Pvt.) Ltd., | 125 mg + 31.25 mg / 5 mL | Suspension | 100ml | 071536 | PKR 229.172026-07-27 |
| Veroclav | CSH Pharmaceuticals (Pvt.) Ltd., | 250 mg + 62.5 mg / 5 mL | Suspension | 100ml | 071537 | PKR 357.772026-07-27 |
| Veroclav | CSH Pharmaceuticals (Pvt.) Ltd., | 250 mg + 125 mg | Tablet | 1x6’s | 071524 | PKR 187.612026-07-27 |
| Veroclav 375mg Dispersible | CSH Pharmaceuticals (Pvt.) Ltd., | 250 mg + 125 mg | Dispersible tablet | 1x6’s | 103639 | PKR 187.612026-07-27 |
| Xenclav | Evolution Pharmaceuticals (Pvt.) Ltd. | 500 mg + 100 mg | IV injection | 1's | 087664 | PKR 199.472026-07-29 |
| Xenclav | Evolution Pharmaceuticals (Pvt.) Ltd. | 1 g + 200 mg | IV injection | 1's | 087665 | PKR 339.102026-07-29 |
| Zamoclav | M/s. Zafa Pharmaceutical Laboratories (Pvt) Ltd | 500 mg + 125 mg | Tablet | 1 x 10's | 035385 | PKR 407.312026-07-27 |
| Zamoclav | M/s. Zafa Pharmaceutical Laboratories (Pvt) Ltd | 250 mg + 125 mg | Tablet | 1 x 10’s | 035384 | PKR 312.692026-07-27 |
| Zamoclav | M/s. Zafa Pharmaceutical Laboratories (Pvt) Ltd | 500 mg + 100 mg | Injection | 1's | 037383 | PKR 213.272026-07-27 |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.